NEW! Investment Companies Centre
- Login to your account
- Free Membership to Digital Look
- Site Map
- Company A-Z
- Finance A-Z
- News Archive
- Events
- Give Us Feedback
Digital Look
- Company A-Z
- Company Search
- MarketStars Premium
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Mobile Tools / PDA
- Education Guides
- UK Shares
- Investment Companies
- Funds
- International Shares
- Bonds
- Currencies
- Commodities
- Covered Warrants
Virgin Credit Card:
Market Cap
£168.18m
Change Today
10.00p ()
Share Price
475.00p
Update - Directors' Dealings
|
For immediate release |
24 September 2008 |
ABCAM PLC
("Abcam" or "the Company")
Directors' Dealings
Cambridge UK, 24 September 2008: Abcam plc announces that to meet demand from institutional investors the following transactions have been undertaken by Directors:
|
Director |
Number of Shares Sold |
Date sold |
Price per Share Sold (p) |
Subsequent Beneficial Holding |
Percentage of issued Share Capital following sale |
|
David Cleevely |
250,000 |
23 September 2008 |
480 |
3,319,760 |
9.46% |
|
Jonathan Milner |
1,000,000 |
23 September 2008 |
480 |
7,044,960 |
20.07% |
|
Jim Warwick * |
15,000 |
23 September 2008 |
480 |
853,200 |
2.43% |
* 7,500 of these shares were sold by his wife Jane Dominey
For further information please contact:
|
Abcam |
+ 44 (0) 1223 696000 |
|
Jonathan Milner, Chief Executive Officer |
|
|
Jeff Iliffe, Chief Financial Officer |
|
|
|
|
|
Numis Securities |
+ 44 (0) 20 7776 1500 |
|
Nominated Adviser - Michael Meade, Nick Westlake Corporate Broking - James Black |
|
|
|
|
|
Buchanan Communications |
+ 44 (0) 20 7466 5000 |
|
Mark Court / Mary-Jane Johnson |
|
Notes for editors:
About Abcam plc
Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.abcam.com. The antibodies are sold under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalogue of over 45,000 products, most of which are antibodies, from over 200 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company currently employs 180 staff in its three operating companies.
This information is provided by RNS